More Data, More Problems… Leveraging the Azure Import/Export Tool

More Data, More Problems… Leveraging the Azure Import/Export Tool

In today’s market businesses are likely familiar with the enterprise services provided in Azure and have already started planning a cloud transition.  As Azure expands its core offering and more business transition to a cloud platform, the question becomes, “how does an organization move large amounts of data to the cloud, specifically to Azure?”  Introducing the Microsoft Azure Import/Export...

Read More
The SSAE16 Audit Journey: The photo album

The SSAE16 Audit Journey: The photo album

A few months ago, I wrote about the journey of going through an SSAE16 audit.  I compared it to travelling with kids. After the trip, when you’re back in the daily routine, there is a point at which you start to sift through and organize your memories. Maybe you look fondly at your souvenirs. …

Read More
Can geography research help solve population health issues in Chicago? Perspectives of an academic-turned consultant

Can geography research help solve population health issues in Chicago? Perspectives of an academic-turned consultant

By now the concept of a ‘food desert’ has become a common term in diet and obesity research: it is a place where few grocery stores or healthy food options are accessible to residents, and as a result may cause obesity or other health problems. Using the same concept, what if instead we focused on health behaviors and outcomes for those who live in ‘doctor deserts’, in areas where there are...

Read More
How to Capture Market Share Through Data-Driven Drug Discovery

How to Capture Market Share Through Data-Driven Drug Discovery

For years pharmaceutical companies have taken existing drugs and repurposed or repositioned them to create new drugs. These new drugs are often geared towards neglected therapeutic areas. Drug repurposing has always been a solid “go to” strategy and a proven method for mitigating the financial risk of drug discovery and a means of addressing softening market share.…

Read More
M&A in Pharmaceuticals and Medical Devices: How to Stop Value Leakage

M&A in Pharmaceuticals and Medical Devices: How to Stop Value Leakage

Most pharmaceutical executives would argue that M&A is critical to drive shareholder value. Transactions can help realize new discovery capabilities, procure new compounds to strengthen stagnant drug development pipelines, or save money, all of which can create a competitive advantage in the market.  The numbers speak for themselves. In 2015, healthcare M&A increased 66%, reaching a...

Read More
In the “Buy vs. Build” world of Pharma, Does Lab Productivity Still Matter?

In the “Buy vs. Build” world of Pharma, Does Lab Productivity Still Matter?

The cost of developing new drugs averages about $500,000 a day over 12 to 14 years (~$2.5B average cost per new drug). This high development spend has not translated into a meaningful number of additional new medical entities approved by the FDA (about ~35 per year). High development costs and thin pipelines have led many companies to shift towards a strategy of acquiring new drugs by...

Read More
Importance of Cybersecurity: Understanding Preventive “Medicine” to Maintain Cyber Health

Importance of Cybersecurity: Understanding Preventive “Medicine” to Maintain Cyber Health

Believe it or not, information security professionals could learn some lessons from the health and wellness industry. The practice of preventative care can and should be transferred to the information security profession. According to the American College of Preventive Medicine, preventive medicine is defined as “a practice by all physicians to keep their patients healthy“.…

Read More
Five things healthcare companies should look for in a managed services provider

Five things healthcare companies should look for in a managed services provider

As technology continues to transform the healthcare industry, firms that deliver health services, along with healthcare providers, are looking to invest their technology dollars in areas that can have the greatest positive impact on their customers.  When budget time rolls around, decisions need to be made about investing in new innovations versus keeping the lights on.…

Read More
Integration Considerations during M&A Execution for Hospitals and Health Systems

Integration Considerations during M&A Execution for Hospitals and Health Systems

Those who follow the healthcare industry are undoubtedly familiar with the wave of consolidation that has been driven by the passage of the Affordable Care Act and the broader shift in market dynamics in recent years. For hospitals and health systems, pursuing a merger or acquisition can bring operating efficiencies, greater negotiating power due to expanded geographic presence or patient...

Read More
Phone: 312-602-4000
Email: marketing@westmonroepartners.com
222 W. Adams
Chicago, IL 60606
Show Buttons
Share On Facebook
Share On Twitter
Share on LinkedIn
Hide Buttons